Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-328
Closed -$17.1K 1138
2021
Q3
$17.1K Hold
328
﹤0.01% 830
2021
Q2
$15K Hold
328
﹤0.01% 878
2021
Q1
$14.5K Hold
328
﹤0.01% 841
2020
Q4
$12.4K Hold
328
﹤0.01% 837
2020
Q3
$10.3K Hold
328
﹤0.01% 788
2020
Q2
$14.8K Hold
328
﹤0.01% 683
2020
Q1
$12.4K Hold
328
﹤0.01% 652
2019
Q4
$20.7K Hold
328
﹤0.01% 641
2019
Q3
$19.7K Hold
328
﹤0.01% 642
2019
Q2
$23K Hold
328
﹤0.01% 623
2019
Q1
$17.1K Hold
328
﹤0.01% 686
2018
Q4
$19.2K Hold
328
﹤0.01% 636
2018
Q3
$23.8K Hold
328
﹤0.01% 649
2018
Q2
$19.5K Hold
328
﹤0.01% 678
2018
Q1
$21.6K Hold
328
﹤0.01% 660
2017
Q4
$31.5K Hold
328
﹤0.01% 574
2017
Q3
$34.3K Buy
+328
New +$33.5K ﹤0.01% 556

Other funds holding VEON

RBC Europe's VEON Position: Q4 2021 in Review

RBC Europe sold out of VEON (VEON) in Q4 2021, closing a stake of 328 shares — an estimated $17.1K sold.

RBC Europe first reported a position in VEON in Q3 2017 and held it in 17 quarters. The position peaked at $34.3K in Q3 2017. 131 funds tracked by Wall St. Rank hold VEON as of Q4 2021.

  • RBC Europe reported no remaining VEON position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 328 VEON shares in Q4 2021, an estimated $17.1K.
  • RBC Europe first reported a position in VEON in Q3 2017 and held it in 17 quarters.
  • RBC Europe's VEON position peaked at $34.3K in Q3 2017.
  • 131 funds tracked by Wall St. Rank held VEON as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.